Ascribe Bioscience Inc.

CIK 1882999 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ascribe Bioscience Inc..

Recent SEC filings

FiledFormAccession number
Oct 15, 2025D0001882999-25-000002
Oct 7, 2024D0001882999-24-000001
Aug 3, 2022D0001882999-22-000001
Sep 15, 2021D0001882999-21-000001